Lobbying Filing Details

Total Spending

$60,000

Activities

3

Lobbyists

4

Gov't Entities

6

Filing Information
Filing UUID:
3f2d5e8d-39df-460e-928b-7ffb42e09725
Type:
Q2 - 2nd Quarter - Report
Period:
2026 - 2nd Quarter (Apr 1 - June 30)
Date Posted:
July 21, 2026 at 2:09 AM
Income:
$60,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Tazeen Ahmad
Registrant
CAPITOL HILL CONSULTING GROUP

Government Relations Firm

Washington, District of Columbia
Client
TEVA PHARMACEUTICALS USA

Generic and biosimilar manufacturer.

District of Columbia, United States of America
Lobbying Activities (3)
Activity 1
Health Issues

Issues surrounding US Pharmaceutical supply chain. Issues surrounding the generic drug and biosimilar user free agreements. Issues surrounding the regulation of complex generic drugs. Issues related to Inflation Reduction Act. Issues related to generic drug review.

Lobbyists (4)
  • BRIAN SUTTER
  • EMILY ELIZABETH WILKINSON-HOLLAND
  • MR. CHRISTOPHER DAVIS
  • KIMBERLEE TRZECIAK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 2
Medicare/Medicaid

Issues surrounding Medicare reimbursement of generic drugs and biosimilars. Issues relating to the impact of prescription drug negotiation on generic drugs. Issues related to drug shortages. Issues related to drug pricing including drug negotiation.

Lobbyists (4)
  • BRIAN SUTTER
  • EMILY ELIZABETH WILKINSON-HOLLAND
  • MR. CHRISTOPHER DAVIS
  • KIMBERLEE TRZECIAK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 3
Trade (domestic/foreign)

Issues related to potential tariffs on generic drugs.

Lobbyists (4)
  • BRIAN SUTTER
  • EMILY ELIZABETH WILKINSON-HOLLAND
  • MR. CHRISTOPHER DAVIS
  • KIMBERLEE TRZECIAK
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 17, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.